March 1, 2021 Press release - Regulatory Targovax ASA: Exercise of options under LTI program and resolution to increase the share capital
February 24, 2021 Press release - Non-regulatory Targovax: Proposal for Remuneration Guidelines for Board and Executive Management
February 23, 2021 Press release - Non-regulatory Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up
February 18, 2021 Press release - Non-regulatory Reminder: Invitation to Targovax’s Capital Markets Day 18 February 2021
February 15, 2021 Press release - Non-regulatory Targovax receives Fast-Track designation for ONCOS-102
February 11, 2021 Press release - Non-regulatory Agenda for Targovax’s Capital Markets Day 18 February 2021
February 10, 2021 Press release - Non-regulatory Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality
February 9, 2021 Press release - Non-regulatory SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102
January 11, 2021 Press release - Non-regulatory Targovax to present at the H.C. Wainwright Virtual BioConnect 2021 Conference
January 6, 2021 Press release - Non-regulatory Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Singapore
